|
Aug 30
|
Biotech Stocks Are Showing Signs of Life. Why the Rally Could Continue.
|
|
Aug 30
|
How Gilead Sciences, Virtus Investment And Hess Midstream Could Put Cash In Your Pocket
|
|
Aug 30
|
Insider Sale: Johanna Mercier Sells 9,513 Shares of Gilead Sciences Inc (GILD)
|
|
Aug 28
|
Here's Why a Handful of Pharmaceutical Stocks Rose Wednesday
|
|
Aug 27
|
“The Adventure Jar,” Showcases a Family Navigating the Challenges of a Cancer Diagnosis and Finding Magic in Time Together
|
|
Aug 26
|
Gilead (GILD) Gains 16.8% in 3 Months: How Should You Play the Stock?
|
|
Aug 20
|
How To Earn $100 Per Month From Gilead Sciences Stock
|
|
Aug 20
|
Gilead Sciences: "One of Best Employers for Women" by Forbes
|
|
Aug 20
|
Building a Bridge to a Healthier World for Youth in Africa with Gilead Sciences
|
|
Aug 19
|
Gilead partners with PANTHERx for LIVDELZI distribution
|
|
Aug 17
|
Gilead (GILD) Obtains FDA Approval for PBC Drug Livdelzi
|
|
Aug 15
|
Gilead’s PBC therapy Livdelzi bags accelerated approval
|
|
Aug 15
|
FDA Approves Gilead's Seladelpar For Inflammatory Liver Disease, Acquired Via $4B CymaBay Deal
|
|
Aug 15
|
FDA clears Gilead drug acquired in $4.3B buyout
|
|
Aug 14
|
Insider Sale: Johanna Mercier Sells 5,490 Shares of Gilead Sciences Inc (GILD)
|
|
Aug 14
|
Gilead’s Livdelzi (Seladelpar) Granted Accelerated Approval for Primary Biliary Cholangitis by U.S. FDA
|
|
Aug 14
|
7 Defensive Stocks to Buy as Investors Seek Shelter
|
|
Aug 3
|
2 Unstoppable Dividend Stocks to Buy if There's a Stock Market Sell-Off
|
|
Aug 2
|
Should You Buy, Sell or Hold Gilead Sciences (GILD) Before Q2 Earnings?
|
|
Aug 1
|
Gilead Sciences (GILD) Advances While Market Declines: Some Information for Investors
|